Skip to main content
Home

Main navigation

  • About HIPRA

      About HIPRA

    • Discover HIPRA
    • History
    • Sustainability & CSR
    • HIPRA Around the World
  • Animal Health

      Animal Health

    • Products
      • Vaccines
      • Diagnostic kits
      • Pharmaceuticals
    • Services
      • About Smart Vaccination
      • HIPRASTATS
      • HIPRA Diagnos
      • HIPRA University
      • Online Calculators
    • Knowledge
    • News
    • Solutions for
      • Swine
      • Poultry
      • Cattle
      • Sheep and goats
      • Rabbits
      • Fish
      • Dogs
  • Human Health

      Human Health

    • Products
      • Covid-19 Vaccine
      • GoodGut: digestive health
    • R&D projects
    • News
    • Press
  • Careers
  • Contact us
Career
Search
Search

Human Health News

who we are
Human Health News

The European RBDCOV project will study HIPRA’s Covid-19 vaccine in children, adolescents and immunocompromised patients

24-03-2022
Human
Explore
RBDCOV

HIPRA plans to produce 400 million doses of its SARS-CoV-2 HIPRA vaccine during 2022

16-04-2021
Human
Explore

HIPRA takes a firm step towards human health with research and manufacture of a Covid-19 vaccine

11-12-2020
Human
Explore

HIPRA makes its biotechnology facilities and equipment available to the health authorities

26-03-2020
Human
Explore

HIPRA at your side to guarantee service (COVID-19)

19-03-2020
Human
Explore
Home

Footer second

  • About HIPRA
  • Animal Health
  • Human Health

Footer third

  • Careers
  • Contact us

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Terms of use
  • Privacy policy
  • Cookies policy